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A Microfabricated Platform for 
Generating Physiologically-
Relevant Hepatocyte Zonation
William J. McCarty, O. Berk Usta & Martin L. Yarmush
In vitro liver models have been important tools for more than 40 years for academic research and 
preclinical toxicity screening by the pharmaceutical industry. Hepatocytes, the highly metabolic 
parenchymal cells of the liver, are efficient at different metabolic chemistries depending on their 
relative spatial location along the sinusoid from the portal triad to the central vein. Although replicating 
hepatocyte metabolic zonation is vitally important for physiologically-relevant in vitro liver tissue 
and organ models, it is most often completely overlooked. Here, we demonstrate the creation of 
spatially-controlled zonation across multiple hepatocyte metabolism levels through the application 
of precise concentration gradients of exogenous hormone (insulin and glucagon) and chemical 
(3-methylcholanthrene) induction agents in a microfluidic device. Observed gradients in glycogen 
storage via periodic acid-Schiff staining, urea production via carbamoyl phosphatase synthetase I 
staining, and cell viability after exposure to allyl alcohol and acetaminophen demonstrated the in vitro 
creation of hepatocyte carbohydrate, nitrogen, alcohol degradation, and drug conjugation metabolic 
zonation. This type of advanced control system will be crucial for studies evaluating drug metabolism 
and toxicology using in vitro constructs.
In vitro liver models are important tools that have been used in various forms for more than 40 years for basic 
science and translational academic research and preclinical toxicity screening by the pharmaceutical industry. 
Hepatocytes are highly metabolic parenchymal liver cells that perform the carbohydrate metabolism, nitrogen 
metabolism, alcohol degradation, and drug conjugation functions, among others, of the liver. Monolayer cultures 
of homogenously-treated hepatocytes have traditionally been used as a first-order approximation of liver tissue1,2. 
However, the metabolism of hepatocytes is not uniform across the liver.
Hepatocytes are efficient at different metabolic processes depending on their relative spatial location along 
the sinusoid. This zonation of distinct metabolisms occurs from the portal triad blood supply (periportal or zone 
1) to the venous drain (pericentral, perivenous, or zone 3) with intermediate or zone 2 cells in between3–6. The 
importance of recapitulating this hepatocyte metabolic heterogeneity in vitro to create more physiological liver 
models has been acknowledged for at least 20 years7. Zone 1 hepatocytes are efficient at glucose release from gly-
cogen stores and pyruvate during the post-absorptive phase8–10, urea formation from ammonia and amino acid 
breakdown10,11, cholesterol biosynthesis12, and phase II conjugation of xenobiotics into polar entities for excre-
tion13–16. Zone 3 hepatocytes are efficient at glucose uptake and storage as glycogen10,17, glutamine formation from 
ammonia10,11,18, alcohol degradation19, and phase I drug conjugation of xenobiotic compounds via cytochrome 
P450 monooxygenases14,20–24. This change in metabolism occurs over the length of the sinusoid, which contains 
approximately 25 cells2.
Despite the distinct metabolic signatures of hepatocytes in different zones, in vitro systems modelling the 
liver, including both static and flow plate and microfluidic devices, typically ignore these large metabolic gradi-
ents. While several papers have reported success using cell consumption-based oxygen gradients25–27 to mimic 
selected zonated hepatocyte functions across a large number of cells in vitro, it is increasingly clear that replication 
of the physical environment within the liver, the parameters classically understood to induce zonation8,28, is not 
sufficient to achieve zonation across many metabolic functions29. The underlying spatial differences in hepatocyte 
genetic expression that are initially defined during development play a dominant role30,31, suggesting that the 
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direct control of hepatocyte function using hormone or chemical stimulation rather than consumption-based 
oxygen gradients, may be necessary to create in vitro zonation of multiple metabolisms.
Here, we demonstrate the creation of spatially-controlled zonation across multiple hepatocyte metabolisms 
in vitro, including examples of carbohydrate, nitrogen, alcohol degradation, and drug conjugation metabolisms, 
through the controlled application of concentration gradients of exogenous hormone and chemical induction 
agents, independent of hepatocyte consumption. In addition to recapitulating the zonation of glucose storage and 
urea production, this in vitro model mimics the zonal toxicity responses of the liver to example environmental 
agents and pharmaceuticals.
Results
Validation of the concentration and flow pattern. Microfluidic devices with a two inlet Christmas tree 
gradient were fabricated to allow the creation of a gradient of soluble factors based on the inlet concentrations 
across the main cell culture channel after seeding and attachment of primary rat hepatocytes (Fig. 1a,b). The con-
centration and flow patterns predicted using numerical simulation were very similar to those found experimen-
tally. Both the numerical (Fig. 1c) and experimental (Fig. 1d) data showed five concentration channels generated 
by mixing inlets 1 and 2 that were maintained along the channel length. The concentration profile was quantified 
using image analysis, as described below, which confirmed that the channel concentrations measured for n = 3 
devices were within the standard deviation of the predicted values (Fig. 1e). The predicted expansion and contrac-
tion of the flow lines at the channel intersection was also confirmed experimentally.
Carbohydrate metabolism. During the absorptive phase, glucose is predominantly taken up and stored 
as glycogen by zone 3 hepatocytes, while during the post-absorptive phase, glucose is preferentially released by 
zone 1 hepatocytes8 (Fig. 2a). The hepatocytes were induced for 24 hr with basal media or media with a hor-
monal concentration gradient of the insulin-to-glucagon ratio. Channel-wide (Fig. 2b) representative images of 
the hepatocytes after PAS staining showed the basal (Fig. 2c) and hormone gradient-induced (Fig. 2d) glycogen 
storage. Quantification of the PAS staining across the width of the device relative to the basal staining intensity 
showed a gradient in glycogen storage (Fig. 2e, Supplemental Fig. 1a), demonstrating a gradient in carbohydrate 
metabolism (Fig. 2f).
Nitrogen metabolism. Glutamine and ammonia are predominantly taken up by zone 1 hepatocytes and 
converted to urea through the ornithine cycle29, which depends on the activity of carbamoyl phosphate synthetase 
1 (CPS1) (Fig. 3a). As above, the hepatocytes were induced for 24 hr with basal media or media with a hormo-
nal concentration gradient of the insulin-to-glucagon ratio. Channel-wide (Fig. 3b) representative images of the 
hepatocytes after CPS1 staining showed the basal (Fig. 3c) and hormone gradient-induced (Fig. 3d) CPS1 inten-
sities. Quantification of the CPS1 staining across the width of the device relative to the basal staining intensity 
(Fig. 3e) suggested a gradient in urea production (Supplemental Fig. 1b), demonstrating an in vivo-like gradient 
in nitrogen metabolism (Fig. 3f).
Alcohol degradation. In the liver, allyl alcohol is oxidized by alcohol dehydrogenase to the reactive alde-
hyde acrolein, which leads to preferential zone 1 cell death32 via lipid peroxidation if the protective phase II glu-
tathione conjugation mechanism is overwhelmed33 (Fig. 4a). The hepatocytes seeded in each device were induced 
for 24 hr with basal media or media with a concentration gradient of 3-methylcholanthrene (3-MC). Here, the 
hepatocytes remained uniformly viable after gradient induction of glutathione conjugation with 3-MC34 (Fig. 4b). 
Representative images of the hepatocytes after uniform exposure to allyl alcohol showed complete cell death in 
the non-induced devices (Fig. 4c), but a gradient in viability after 3-MC induction (Fig. 4d). The quantified viabil-
ity across the width of the device (Fig. 4e) suggested a gradient in glutathione conjugation activity, demonstrating 
an in vivo-like gradient in alcohol degradation (Fig. 4f).
Drug conjugation metabolism. Acetaminophen (APAP) is bioactivated by various CYP enzymes in the 
liver to the cytotoxic intermediate NAPQI, which depletes glutathione, leading to cell death after overdose35. 
Only hepatocytes in zone 3 contain high CYP activity, making APAP a zone 3 toxin (Fig. 5a). The hepato-
cytes seeded in each device were induced for 24 hr with basal media or media with a concentration gradient of 
3-methylcholanthrene. Here, the hepatocytes remained uniformly viable after gradient induction of CYP activity 
with 3-MC34 (Fig. 5b). Representative images of the hepatocytes after uniform exposure to APAP showed viable 
cells in the non-induced devices (Fig. 5c), but a gradient in viability after 3-MC induction (Fig. 5d). The quanti-
fied viability across the width of the device (Fig. 5e) suggested a gradient in CYP activity (Supplemental Fig. 1c), 
demonstrating an in vivo-like gradient in drug conjugation metabolism (Fig. 5f).
Discussion
These results demonstrate the induction of gradients in a variety of hepatocyte metabolisms during in vitro cul-
ture within a microdevice. We modified hepatocyte metabolism through short-term (24 hr) concentration gra-
dient induction with hormones (insulin and glucagon) or a chemical (3-MC) (Fig. 1). This induction produced a 
change from zone 1-like to zone 3-like hepatocyte metabolisms across approximately 25–40 cells, similar to the 
magnitude of change occurring along the sinusoid in vivo. The hormonal induction gradient produced hepato-
cytes with zonated glycogen storage (Fig. 2) and CPS1 content (Fig. 3), indicating zonation of carbohydrate and 
nitrogen metabolisms. The chemical induction gradient produced hepatocytes with zonated viability in response 
to glutathione-dependent zone 1 toxin allyl alcohol (Fig. 4) and CYP activity-dependent zone 3 toxin acetami-
nophen (Fig. 5), indicating zonation of alcohol degradation and drug conjugation metabolisms and providing 
example applications of the utility of the system.
www.nature.com/scientificreports/
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Figure 1. Device design, seeding, and the simulated and experimental concentration and flow patterns. 
(a) AutoCAD schematic of the device design showing the Christmas tree gradient connecting two inlets to the 
cell culture field. Left and right cell seeding ports were blocked after seeding so that flow occurs in the negative 
y-direction to the outlet. (b) Example phase image of a confluent field of hepatocytes seeded in the device with 
% width defined from left to right. (c) COMSOL simulation of and (d) experimental data for fluorescein (inlet 
1: 0 μ g/mL, 0.5 μ L/min; inlet 2: 5 μ g/mL, 0.5 μ L/min). Bar: 200 μ m. (e) Fluorescein concentration quantified 
across the device width based on n = 3 devices. The black line shows the target concentrations and the red the 
experimental data.
www.nature.com/scientificreports/
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There are several limitations to this study. First, we indirectly assessed changes in CYP and glutathione activ-
ities, urea production, and glucose release and uptake by hepatocytes in the devices by assessing the cell viability 
and CPS1 and glycogen staining intensities. However, pilot data in plates did show increases in CYP activity and 
urea production by hepatocytes cultured under similar conditions in plates (Supplemental Fig. 1). Unfortunately, 
those assays could not be easily translated to a continuous field of cells in a microdevice. Second, the hepat-
ocyte metabolisms were assessed separately for the two inducers tested: carbohydrate and nitrogen metabo-
lisms induced with hormones and alcohol degradation and drug conjugation metabolisms induced with 3-MC. 
Combining these inducers to create zonation across all metabolisms assessed would present a more physiological 
sinusoid. Third, the timeline of the experiments was limited by the loss of hepatocyte function over time that 
occurs when the cells are not cultured under a collagen gel36 or nanolayer assembly37. These experiments were 
performed within 48 hours of cell isolation, but some applications may require a longer time frame. Despite these 
Figure 2. Zonation of carbohydrate metabolism in vitro. (a) During the absorptive phase, glucose is 
predominantly taken up and stored as glycogen by zone 3 hepatocytes, while during the post-absorptive phase, 
glucose is preferentially released by zone 1 hepatocytes. (b) Device design showing location of the images within 
the device. (c) PAS staining for glycogen in hepatocytes under basal conditions. (d) Glycogen in hepatocytes 
after 24 hr induction with a gradient of the insulin-to-glucagon ratio (inlet 1: 100 nM glucagon, 0 U/L insulin; 
inlet 2: 0 nM glucagon, 100 U/L insulin). (e) Quantification of glycogen staining intensity across the width of 
the device (n = 4 induced devices; repeated effect of location (% width): P < 0.001). (f) Diagram showing the 
zonation of carbohydrate metabolism induced across the field of hepatocytes. Bars: 200 μ m.
www.nature.com/scientificreports/
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limitations, the data presented here demonstrate creation of zonation in four categories of hepatocyte metabolism 
over a physiologically-relevant number of cells and length-scale.
The zonation of hepatocyte metabolism created here better mimics the metabolic functions of the liver sinu-
soid than static hepatocyte cultures by providing physically- and biologically-connected cells with spatially vary-
ing metabolic functions. These connections provide fields of cells with continuous changes in metabolic function 
over a physiologically-relevant number of cells (as demonstrated in Figs 2–5) that can communicate with their 
neighbors, as occurs in the liver. Creating five independent cultures of cells that experience identical conditions 
as their neighbors may be able to replicate the average cellular metabolic response, but requires 5-fold more 
resources and precludes any physical or biological intercellular interaction between cells with varied metabolic 
responses, both of which occur between neighboring hepatocytes physiologically. Thus, the practical advantages 
of this approach over isolated culture systems include physical and biological coupling of cells with varied met-
abolic responses, spatial variation in the response to stimuli (Figs 4 and 5) – a hallmark of liver physiology, and 
increased throughput.
Figure 3. Zonation of nitrogen metabolism in vitro. (a) Glutamine and ammonia are predominantly taken 
up by zone 1 hepatocytes and converted to urea through the ornithine cycle, which depends on the activity of 
carbamoyl phosphate synthetase 1 (CPS1). (b) Device design showing location of the images within the device. 
(c) Staining for CPS1 in hepatocytes under basal conditions. (d) CPS1 in hepatocytes after 24 hr induction with 
a gradient of the insulin-to-glucagon ratio (inlet 1: 100 nM glucagon, 0 U/L insulin; inlet 2: 0 nM glucagon,  
100 U/L insulin). (e) Quantification of CPS1 staining intensity across the width of the device (n = 7 basal,  
n = 6 induced devices; fixed effect of induction: P < 0.001; repeated effect of location (% width): P < 0.001).  
(f) Diagram showing the zonation of nitrogen metabolism induced across the field of hepatocytes. Bars: 200 μ m.
www.nature.com/scientificreports/
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Beyond establishing the gradient in alcohol degradation (Fig. 4) and drug conjugation (Fig. 5) metabolisms, 
the data in Figs 4 and 5 are example applications that demonstrate ability of this system to distinguish likely 
modes of toxicity. For example, CYP-dependent toxicity occurs in Zone 3 hepatocytes because only those hepat-
ocytes have enough CYP activity to create sufficiently high concentrations of toxic metabolites to cause cell death 
(Fig. 5). Similarly, direct toxins and those that require phase II-conjugation for safe elimination result in Zone 
1 cell death (Fig. 4). Fundamental questions, such as the zonal region and likely mode of liver toxicity, can be 
answered in this culture system because of the spatial gradient in cell metabolism.
In contrast to the gradient of hepatocyte metabolisms established here, traditional static culture methods 
by design produce fields of cells uniform in function. For example, many methods of static hepatocyte culture 
include high levels of hormones, insulin in particular, and growth factors in the media, producing a uniform 
Figure 4. Zonation of alcohol degradation in vitro. (a) Allyl alcohol is oxidized by alcohol dehydrogenase 
(ADH) to the reactive aldehyde acrolein, which leads to preferential zone 1 cell death via lipid peroxidation if 
the protective phase II glutathione conjugation mechanism is overwhelmed. (b) After 24 hr induction with a 
gradient of 3-methylcholanthrene (3-MC) (inlet 1: 0 μ M 3-MC, inlet 2: 2 μ M 3-MC) or media (non-induced; 
inlet 1: media, inlet 2: media), the hepatocytes remained viable. After uniform exposure to an overdose of allyl 
alcohol (200 μ M) for 2 hr, the (c) non-induced cells all died, while (d) induction led to a gradient in cell viability, 
indicating a gradient in protective alcohol degradation. (e) Quantification of viability across the width of the 
device (n = 6 non-induced, n = 6 induced devices; fixed effect of induction: P < 0.001; repeated effect of location 
(% width): P < 0.001). (f) Diagram showing the zonation of alcohol degradation induced across the field of 
hepatocytes. Bars: 200 μ m.
www.nature.com/scientificreports/
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layer of zone 3-like cells. This leads to both under- and over-prediction of the hepatotoxicity of a drug depending 
on the mechanism. Zone 1 toxins, such as allyl alcohol (Fig. 4), may be under-reported if zone 3-like cells, con-
taining increased glutathione conjugation and CYP activities, are used. On the other hand, over-prediction of 
LDH-leakage or other markers of hepatocyte toxicity may occur for zone 3 toxins, such as APAP (Fig. 5), because 
most hepatocytes in the liver lack the CYP activity necessary to create the toxic reactive intermediates. Similarly, 
the hepatocyte cultures with zonated carbohydrate and nitrogen metabolisms are more physiologically relevant 
culture systems than uniform hepatocyte monolayer cultures for basic science investigations because they provide 
spatially-controlled, heterogeneous metabolic function as is found in the liver.
Figure 5. Zonation of drug conjugation metabolism in vitro. (a) Acetaminophen (APAP) is bioactivated by 
various CYP enzymes to the cytotoxic intermediate NAPQI, which depletes glutathione, leading to cell death 
after overdose. Only hepatocytes in zone 3 contain high CYP activity, making APAP a zone 3 toxin. (b) After 
24 hr induction with a gradient of 3-methylcholanthrene (3-MC) (inlet 1: 0 μ M 3-MC, inlet 2: 2 μ M 3-MC) or 
media (non-induced; inlet 1: media, inlet 2: media), the hepatocytes remained viable. After uniform exposure to 
an overdose of APAP (10 mM) for 4 hr, the (c) non-induced cells all remained viable, while (d) induction led to 
a gradient in cell viability, indicating a gradient in CYP activity. (e) Quantification of viability across the width 
of the device (n = 6 non-induced, n = 6 induced devices; fixed effect of induction: P < 0.001; repeated effect of 
location (% width): P < 0.001). (f) Diagram showing the zonation of drug conjugation induced across the field 
of hepatocytes. Bars: 200 μ m.
www.nature.com/scientificreports/
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In this device, the spatial gradient in metabolism is perpendicular to the flow direction, while in the liver the 
zonation of hepatocyte metabolism occurs along the flow direction. However, the underlying spatial differences 
in hepatocyte genetic expression initially defined during development play a dominant role30,31 in determining 
hepatocyte metabolism, with flow-direction consumption-based dynamic mediators, such as oxygen, playing a 
less important role. As a substitute for this spatial genetic control, we imposed precise chemical control of hepat-
ocyte metabolism perpendicular to the flow direction, which allowed us to define cell metabolism independent of 
consumption. Further, to minimize any inadvertent effects of this cross-flow on the cells, the flow rate was chosen 
such that the shear stress induced had no effect on the cells40.
Hepatocyte cultures demonstrating metabolic zonation across a range of metabolisms may allow simultaneous 
testing of efficacy and toxicity for drugs targeting the liver. The liver plays central roles in both the oxidation of 
excess nitrogenous compounds, producing urea, and the regulation of blood glucose levels, providing glycogen 
stores that are a reservoir for glucose. Because of this, the liver is a common target for therapeutic interventions in 
both of these metabolic processes. For example, a culture system with zonated carbohydrate and drug conjugation 
metabolism can show the differential effects of a carbohydrate-modifying drug on hepatocytes at different loca-
tions along the sinusoid at the same time that the toxicity of the drug to zone 1 and zone 3 hepatocytes is defined.
Beyond the soluble hormones and chemical used here for induction, other categories of factors, such as 
genetic modulators, may produce effects over a wider range of hepatocyte expression. The genetic control of 
hepatocyte zonation is defined during development through the zone 1 localization of adenomatous polyposis 
coli, a negative regulator of Wnt/β -catenin signaling30. Wnt signaling imparts zone 3-like genetic expression to 
hepatocytes, while its inhibition imparts zone 1-like genetic expression31. Controlling Wnt/β -catenin signaling 
using the gradient induction microdevice demonstrated here may offer a simpler approach to spatially controlling 
the genetic profile of the hepatocytes.
In conclusion, we demonstrated the induction of spatially-controlled in vitro zonation in hepatocyte carbohy-
drate, nitrogen, alcohol degradation, and drug conjugation metabolisms. The zonation of hepatocyte metabolism 
is an often-overlooked, but vitally important aspect of physiologically-relevant in vitro liver tissue and organ 
models. As many disease states in the liver also exhibit zonation, the creation of zonated liver metabolisms will 
also be essential for the development of in vitro liver disease models.
Methods
Microfluidic device fabrication and preparation. Microfluidic devices were fabricated by replica mold-
ing PDMS from photolithographically defined SU-8 masters on silicon wafers. A 2-inlet, 5-channel Christmas 
tree gradient was used to allow creation of a gradient of the inlet concentrations across the main channel (Fig. 1a). 
PDMS was cast on the molds to a thickness of 2–3 mm and baked overnight at 70 °C. The main cell culture chan-
nel was 100 μ m high, 800 μ m wide, and 4 mm long. Inlet, cell seeding, and outlet ports were punched into the 
devices using 0.5 and 0.75 mm dermal punches. The devices were then plasma cleaned, bonded to microscope 
slides, baked (70 °C, 5 min), UV-sterilized (25 min), and coated with fibronectin (50 μ g/mL, 37 °C, 45 min) in PBS 
before cell seeding.
Hepatocyte isolation and culture. The protocols for the following experiments were approved by the 
Institutional Animal Care and Use Committee of Massachusetts General Hospital. The methods were car-
ried out in accordance with the approved guidelines. Primary rat hepatocytes were freshly isolated from adult 
female Lewis rats (Charles River Laboratories, Wilmington, MA) weighing 180–200 g, by a modified procedure 
of Seglen38, as described previously39. Routinely, 200–300 million cells with 90–95% viability were isolated, as 
determined by trypan blue exclusion. Rat hepatocytes were seeded in Dulbecco’s modified eagle’s medium (Life 
Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS, Sigma, St. Louis, MO, USA), 
0.5 U/mL insulin, 7 ng/mL glucagon, 20 ng/mL epidermal growth factor, 7.5 μ g/mL hydrocortisone, 200 U/mL 
penicillin, 200 μ g/mL streptomycin, and 50 μ g/mL gentamycin. The hepatocytes were seeded into devices (20 μ L 
at 15 M cells/mL), allowed to attach for 3–4 hours, and then rinsed with fresh media. Finally, the cells were incubated 
overnight at 37 °C in humidified air with 10% CO2. Twenty-four hours after seeding, the cell media was replaced 
with basal, serum-free William’s E supplemented with 4 mM glutamine, 200 U/mL penicillin, and 200 μ g/mL strep-
tomycin (WEB media) that also contained various chemical and hormonal inducers as described below (Fig. 1b).
The total flow rate experienced by the cells during flow was 1.0 μ L/min, with 0.5 μ L/min moving through each 
inlet. This flow rate was chosen as sufficiently fast to prevent significant diffusive mixing of the channels, but also 
slow enough to limit the shear stress on the cells to less than 0.1 dynes/cm2. Shear stress values of 0.3 dynes/cm2 
were previously shown to have no detrimental effects on cultured primary rat hepatocytes40.
Zonation of hepatocyte carbohydrate and nitrogen metabolisms. Hormone Ratio Induction. 
Gradients in hepatocyte carbohydrate and nitrogen metabolisms were induced using an applied gradi-
ent in the ratio of insulin-to-glucagon. WEB media supplemented with 100 nM glucagon and 0 U/L insulin 
(inlet 1, 0.5 μ L/min) and 0 nM glucagon and 100 U/L insulin (inlet 2, 0.5 μ L/min) was pumped through devices 
placed inside an incubator for 24 hr.
Carbohydrate Metabolism. After induction with the hormone ratio gradient, periodic acid-Schiff (PAS) staining for 
glycogen following the manufacturer’s instructions (Sigma-Aldrich, St. Louis, MO) was used as a marker of glucose 
uptake and release by the hepatocytes in the devices. The average greyscale intensity of the PAS staining of each pixel 
across the width of each device was quantified on bright-field microscopy images using a custom image processing 
script (MATLAB, MathWorks, Natick, MA; ImageJ, NIH, Bethesda, MD). For each image, the script summed the 
greyscale intensities of each column of pixels to create a vector of total intensity at each pixel across the width of the 
device. The intensities were then normalized to the baseline controls and reported as a change in greyscale value.
www.nature.com/scientificreports/
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Nitrogen Metabolism. After induction with the hormone ratio gradient, immunofluorescent staining for carba-
moyl phosphate synthetase 1 (CPS1; 1:100, ab3682, abcam, Cambridge, MA) with an Alexa Fluor 488-conjugated 
secondary (1:200, ab150073, abcam) was used as a marker for the production of urea by the ornithine cycle. The 
total fluorescence intensity for each column of pixels across the width of each device was quantified using the cus-
tom image processing script above and normalized to the basal cell intensity as 0 a.u. and to the maximum total 
pixel intensity across the set of images as 100 a.u.
Zonation of hepatocyte alcohol degradation and drug conjugation metabolisms. Chemical induction. 
Zonation of hepatocyte alcohol degradation and drug conjugation metabolisms was induced using an applied 
concentration gradient of 3-methylcholanthrene (3-MC). WEB media alone (inlet 1, 0.5 μ L/min) and WEB sup-
plemented with 2 μ M 3-MC37 (inlet 2, 0.5 μ L/min) was pumped through devices placed inside an incubator with 
the cells thus experiencing 1 μ L/min flow for 24 hr. 3-MC induces the expression of CYP and glutathione drug 
conjugation enzymes in hepatocytes34.
Alcohol degradation. After induction with 3-MC, the flow was stopped and all the cells in each device were 
exposed to a toxic dose41 of the zone 1 toxin allyl alcohol (200 μ M) for 2 hr at 37 °C. The average fluorescent signal 
at each pixel across the width of the device from tetramethylrhodamine methyl ester (TMRM; 500 nM in WEB, 
20 min, 37 °C), which is sequestered by active mitochondria, was used as an indicator of cell viability. The images 
were automatically binarized in ImageJ, processed using the custom script as above, and normalized as a percent 
of the range between the positive and negative controls.
Drug conjugation metabolism. After induction with 3-MC, the flow was stopped and all the cells in each device 
were exposed to a toxic dose42 of the zone 3 toxin acetaminophen (10 mM in WEB) for 4 hr at 37 °C. The average 
fluorescent TMRM signal at each pixel across the width of the device was determined as above and used as an 
indicator of cell viability.
Statistical Analysis. The data are presented as mean ± SEM for n = 4–7 devices or wells, derived from at 
least 3 different rat isolations. The effect of location (% device width) on PAS staining was assessed using 1-way 
repeated measures ANOVA. The fixed effect of induction (induced vs. non-induced) and repeated effect of loca-
tion within the device (% device width) on cell viability or staining intensity were assessed using 2-way repeated 
measures ANOVAs. P-values less than 0.05 were considered statistically significant.
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